Hopefully this becomes a family of medications with generations of refinement. This can push off pancreatic, lung, and liver cancer for years in some patients.
This is not off topic. This is also a major business and economic opportunity.
https://www.nytimes.com/2026/05/12/health/pancreatic-cancer-daraxonrasib-kras.html